<?xml version="1.0" encoding="UTF-8"?>
<results title="funders">
 <result pre="R12[1], [2], Correspondence: Raymund R Razonable, Division of Infectious Diseases," exact="Mayo Clinic," post="Mayo Clinic College of Medicine, Marian Hall 5528, 200"/>
 <result pre="Correspondence: Raymund R Razonable, Division of Infectious Diseases, Mayo Clinic," exact="Mayo Clinic" post="College of Medicine, Marian Hall 5528, 200 First Street"/>
 <result pre="The three antiviral drugs that are approved by the US" exact="Food and Drug Administration" post="for CMV treatment are the nucleoside analog GCV, and"/>
 <result pre="orphan drug designation for prevention of CMV disease by the" exact="European Commission." post="In August 2011, the US Food and Drug Administration"/>
 <result pre="disease by the European Commission. In August 2011, the US" exact="Food and Drug Administration" post="granted it a fast track designation. In 2012, the"/>
 <result pre="structure of letermovir, the antivirals currently approved by the US" exact="Food and Drug Administration," post="and other investigational drugs with anti-CMV activity. Mechanism of"/>
</results>
